Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data

被引:0
|
作者
James B. Young
Marjolaine Gauthier-Loiselle
Robert A. Bailey
Ameur M. Manceur
Patrick Lefebvre
Morris Greenberg
Marie-Hélène Lafeuille
Mei Sheng Duh
Brahim Bookhart
Carol H. Wysham
机构
[1] Cleveland Clinic Foundation Lerner College of Medicine of Case Western Reserve University,
[2] Analysis Group,undefined
[3] Inc.,undefined
[4] Janssen Scientific Affairs,undefined
[5] LLC,undefined
[6] Analysis Group Inc.,undefined
[7] Rockwood Clinic,undefined
来源
关键词
Type 2 diabetes mellitus; Cardiovascular disease; Risk prediction; Health insurance claims;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data
    Young, James B.
    Gauthier-Loiselle, Marjolaine
    Bailey, Robert A.
    Manceur, Ameur M.
    Lefebvre, Patrick
    Greenberg, Morris
    Lafeuille, Marie-Helene
    Duh, Mei Sheng
    Bookhart, Brahim
    Wysham, Carol H.
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [2] Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study
    Wysham, Carol H.
    Gauthier-Loiselle, Marjolaine
    Bailey, Robert A.
    Manceur, Ameur M.
    Lefebvre, Patrick
    Greenberg, Morris
    Duh, Mei Sheng
    Young, James B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (02) : 219 - 227
  • [3] Social isolation, loneliness and subsequent risk of major adverse cardiovascular events among individuals with type 2 diabetes mellitus
    Liang, Yannis Yan
    Chen, Yilin
    Feng, Hongliang
    Xue, Huachen
    Nie, Yu
    Ai, Qi-Yong H.
    Ma, Jiacheng
    Yang, Lulu
    Zhang, Jihui
    Ai, Sizhi
    GENERAL PSYCHIATRY, 2023, 36 (06)
  • [4] Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Nissen, SE
    Wolski, K
    Topol, EJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (20): : 2581 - 2586
  • [5] Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Liyao Fu
    Ying Zhou
    Jiaxing Sun
    Zhaowei Zhu
    Zhenhua Xing
    Shenghua Zhou
    Yongjun Wang
    Shi Tai
    Cardiovascular Diabetology, 20
  • [6] Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Fu, Liyao
    Zhou, Ying
    Sun, Jiaxing
    Zhu, Zhaowei
    Xing, Zhenhua
    Zhou, Shenghua
    Wang, Yongjun
    Tai, Shi
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [7] N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Sun, Mingyang
    Lu, Zhongyuan
    Chen, Wan-Ming
    Lv, Shuang
    Fu, Ningning
    Yang, Yitian
    Wang, Yangyang
    Miao, Mengrong
    Wu, Szu-Yuan
    Zhang, Jiaqiang
    ATHEROSCLEROSIS, 2025, 402
  • [8] PREDICTORS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG TYPE 2 DIABETES MELLITUS PATIENTS: A MACHINE LEARNING TIME-TO-EVENT ANALYSIS
    Icten, Z.
    Friedman, M.
    Menzin, J.
    VALUE IN HEALTH, 2022, 25 (07) : S291 - S292
  • [9] The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes
    Chang, Chi-Wei
    Liao, Kuo-meng
    Chang, Yi-Ting
    Wang, Sheng-Hung
    Chen, Ying-chun
    Wang, Gin-Chung
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (02) : 160 - 164
  • [10] HEART Score Classification of Major Adverse Cardiovascular Events in Patients with Diabetes Mellitus
    Alhamaydeh, Mohammad
    Helman, Stephanie
    AlQaqaa, Ahmed
    Luo, Huabin
    Al-Zaiti, Salah
    CIRCULATION, 2024, 150